Skaana Management’s Medigus Ltd. Series C Warrant MDGSW Stock Holding History

Skaana Management’s Portfolio MDGSW Stock Details MDGSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-67,920	Closed	-$2.31K	–	229
2023 Q2	$2.31K	Buy	+67,920	New	+$4.22K	﹤0.01%	158
2022 Q4	–	Sell	-70,200	Closed	-$7K	–	220
2022 Q3	$7K	Hold	70,200	–	–	﹤0.01%	80
2022 Q2	$17K	Hold	70,200	–	–	﹤0.01%	85
2022 Q1	$19K	Sell	70,200 -4,800	-6%	-$1.55K	﹤0.01%	91
2021 Q4	$16K	Buy	+75,000	New	+$27.9K	﹤0.01%	166

Skaana Management's MDGSW Position: Q3 2023 in Review

Skaana Management sold out of Medigus Ltd. Series C Warrant (MDGSW) in Q3 2023, closing a stake of 67,920 shares — an estimated $2.31K sold.

Skaana Management first reported a position in MDGSW in Q4 2021 and held it in 5 quarters. The position peaked at $19K in Q1 2022. 0 funds tracked by Wall St. Rank hold MDGSW as of Q3 2023.

Skaana Management reported no remaining Medigus Ltd. Series C Warrant position as of Q3 2023 after selling out during the quarter.
Skaana Management sold 67,920 Medigus Ltd. Series C Warrant shares in Q3 2023, an estimated $2.31K.
Skaana Management first reported a position in Medigus Ltd. Series C Warrant in Q4 2021 and held it in 5 quarters.
Skaana Management's Medigus Ltd. Series C Warrant position peaked at $19K in Q1 2022.
0 funds tracked by Wall St. Rank held Medigus Ltd. Series C Warrant as of Q3 2023.

Based on Skaana Management's 13F filing for Q3 2023, filed 14 Nov 2023.